Kang YM, Giugliano RP, Keech AC, Lopez JAG, et al. Obesity-Associated Cardiovascular Risk and Benefit From PCSK9 Inhibition: A Prespecified Analysis From FOURIER. J Am Coll Cardiol 2025 Dec 10:S0735-1097(25)10005.
PMID: 41369622